Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Infectious Diseases (CID)
Updated infectious diseases guidance addresses resistant gram-negative infections through pathogen-specific treatment pathways, incorporating newer antibiotics and pharmacologic considerations while acknowledging that several preferred approaches rest on limited clinical outcomes data.
Clinical Pharmacology November 3rd 2026
Optometry Advisor
The FDA warned that counterfeit over-the-counter eye drops found in several states may contain bacterial contamination capable of causing serious ocular infections. No associated adverse events had been reported when the warning was issued.
Ophthalmology October 30th 2026
MDLinx
Extensively drug-resistant Shigella has increased in US surveillance, with sexual transmission emerging as an important route among some populations. Rising multidrug resistance may complicate treatment, although many infections remain self-limited.
Emergency Medicine October 16th 2026
The Journal of Infectious Diseases (JID)
Children exposed to maternal Tdap vaccination had lower pertussis toxin and diphtheria antibody concentrations at ages 3 and 4, but their responses matched controls after a preschool DTaP booster in this small Finnish follow-up.
Family Medicine/General Practice October 8th 2026
Journal of the American Academy of Physician Associates (JAAPA)
Neonatal sepsis affects an estimated 22 per 1,000 live births globally and carries significant morbidity risk, with PA-authored CME examining risk stratification, diagnostic sequencing, and antimicrobial stewardship for the practicing provider.
Obstetrics & Gynecology June 18th 2026
Physician’s Weekly
“This review aims to inform strategies for early diagnosis, promote rational antibiotic use to mitigate antimicrobial resistance, and guide the development of future therapeutic approaches.” – Lead Author Sebastien Kenmoe, PhD, University of Edinburgh
Emergency Medicine April 9th 2026